Dark
Light
Today: July 22, 2024
June 30, 2024
1 min read

Esper Bionics Raises $5M to Scale Bio-Prosthetics Manufacturing and Innovation

TLDR:

Esper Bionics, a Ukrainian startup, has secured a $5 million investment round to expand its bio-prosthetics production and research efforts. The funding will be used to develop the world’s first bionic ecosystem, with plans to scale up production and modernize existing facilities. The company, founded in 2019, specializes in developing robotic limbs and has already manufactured 30 prosthetics per month, with a goal of reaching 500 by the end of 2024. The startup employs over 55 professionals and operates offices in New York, Lviv, and Berlin, with a focus on the United States market where prosthetics are sold through insurance companies. Additionally, through its social program Esper for Ukraine, 80 Ukrainian defenders have received bionic prosthetics. The total investment in the company since its inception amounts to $7 million.

Esper Bionics, a Ukrainian startup, has secured a $5 million investment round to expand its bio-prosthetics production and research efforts. The funding will be used to develop the world’s first bionic ecosystem, with plans to scale up production and modernize existing facilities. The company, founded in 2019, specializes in developing robotic limbs and has already manufactured 30 prosthetics per month, with a goal of reaching 500 by the end of 2024. The startup employs over 55 professionals and operates offices in New York, Lviv, and Berlin, with a focus on the United States market where prosthetics are sold through insurance companies. Additionally, through its social program Esper for Ukraine, 80 Ukrainian defenders have received bionic prosthetics. The total investment in the company since its inception amounts to $7 million.

Previous Story

June sees $31bn in PE-VC deals, slight MoM drop

Next Story

Vivo VC Funding and Huawei Financing Updates: Finance Insights

Latest from Blog

Antheia Secures $17M Investment

TLDR: Antheia, a pharmaceutical ingredient manufacturer based in Menlo Park, CA, raised $17M in funding. The funding included a non-dilutive two-year project agreement up to $11M through the BioMaP Consortium. Antheia, led
Go toTop